Luciana Chessa

Luciana Chessa

Auto-generated profile, based on publicly available information

Luciana Chessa

Department of Clinical and Molecular Medicine University ‘La Sapienza’ Roma Italy

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1998 in The American Journal of Human Genetics
Verified
Journal Article
Open access
SGShlomit Gilad
Shlomit Gilad
LCLuciana Chessa
Luciana Chessa
RKRami Khosravi
Rami Khosravi
PRPamela Russell
Pamela Russell
YGYaron Galanty
Yaron Galanty
ABAnat Bar-Shira
Anat Bar-Shira
Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, radiosensitivity, and cancer predisposition. A-T cells are sensitive to ionizing radiation and radiomimetic chemicals and fail to activate cell-cycle checkpoints after treatment with these agents. The responsible gene, ATM, encodes a large protein kinase with a phosphatidylinositol 3-kinase-like domain. The typical A-T phenotype is caused, in most cases, by null ATM alleles that truncate or severely destabilize the ATM protein. Rare patients with milder manifestations of the clinical or cellular characteristics of the disease have been reported and have been designated "A-T variants." A special variant form of A-T is A-TFresno, which combines a typical A-T phenotype with microcephaly and mental retardation. The possible association of these syndromes with ATM is both important for understanding their molecular basis and essential for counseling and diagnostic purposes. We quantified ATM-protein levels in six A-T variants, and we searched their ATM genes for mutations. Cell lines from these patients exhibited considerable variability in radiosensitivity while showing the typical radioresistant DNA synthesis of A-T cells. Unlike classical A-T patients, these patients exhibited 1%-17% of the normal level of ATM. The underlying ATM genotypes were either homozygous for mutations expected to produce mild phenotypes or compound heterozygotes for a mild and a severe mutation. An A-TFresno cell line was found devoid of the ATM protein and homozygous for a severe ATM mutation. We conclude that certain "A-T variant" phenotypes represent ATM mutations, including some of those without telangiectasia. Our findings extend the range of phenotypes associated with ATM mutations.

12 October 2016 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
Sara BiagiottiSara Biagiotti
Sara Biagiotti
MMMichele Menotta
Michele Menotta
SOSara Orazi
Sara Orazi
CSChiara Spapperi
Chiara Spapperi
SBSerena Brundu
Serena Brundu
Mauro MagnaniMauro Magnani
Mauro Magnani
Ataxia telangiectasia (A‐T) is a rare incurable neurodegenerative disease caused by biallelic mutations in the gene for ataxia‐telangiectasia mutated (ATM). The lack of a functional ATM kinase leads to a pleiotropic phenotype, and oxidative stress is considered to have a crucial role in the complex physiopathology. Recently, steroids have been shown to reduce the neurological symptoms of the disease, although the molecular mechanism of this effect is largely unknown. In the present study, we have demonstrated that dexamethasone treatment of A‐T lymphoblastoid cells increases the content of two of the most abundant antioxidants [glutathione (GSH) and NADPH] by up to 30%. Dexamethasone promoted the nuclear accumulation of the transcription factor nuclear factor (erythroid‐derived 2)‐like 2 to drive expression of antioxidant pathways involved in GSH synthesis and NADPH production. The latter effect was via glucose 6‐phosphate dehydrogenase activation, as confirmed by increased enzyme activity and enhancement of the pentose phosphate pathway rate. This evidence indicates that glucocorticoids are able to potentiate antioxidant defenses to counteract oxidative stress in ataxia telangiectasia, and also reveals an unexpected role for dexamethasone in redox homeostasis and cellular antioxidant activity.

31 December 2015 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Micol FalabellaMicol Falabella
Micol Falabella
EFElena Forte
Elena Forte
MMMaria Chiara Magnifico
Maria Chiara Magnifico
PSPaolo Santini
Paolo Santini
MAMarzia Arese
Marzia Arese
PSPaolo Sarti
Paolo Sarti
Here we have collected evidence suggesting that chronic changes in the NO homeostasis and the rise of reactive oxygen species bioavailability can contribute to cell dysfunction in Leber’s hereditary optic neuropathy (LHON) patients. We report that peripheral blood mononuclear cells (PBMCs), derived from a female LHON patient with bilateral reduced vision and carrying the pathogenic mutation 11778/ND4, display increased levels of reactive oxygen species (ROS) and reactive nitrogen species (RNS), as revealed by flow cytometry, fluorometric measurements of nitrite/nitrate, and 3‐nitrotyrosine immunodetection. Moreover, viability assays with the tetrazolium dye MTT showed that lymphoblasts from the same patient are more sensitive to prolonged NO exposure, leading to cell death. Taken together these findings suggest that oxidative and nitrosative stress cooperatively play an important role in driving LHON pathology when excess NO remains available over time in the cell environment.

1 April 1991 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
PIPaola Iannetti
Paola Iannetti
LCLuciana Chessa
Luciana Chessa
GIGiorgio Iannetti
Giorgio Iannetti

30 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
FPFrancesco Pappalardo
Francesco Pappalardo
VSValentina Di Salvatore
Valentina Di Salvatore
Giulia RussoGiulia Russo
Giulia Russo
GNGiulia Nicotra
Giulia Nicotra
AMAvisa Maleki
Avisa Maleki
APAgata Polizzi
Agata Polizzi
Ataxia Telangiectasia (AT) is a rare multisystem disorder caused by pathogenic variants in the ATM gene and mainly characterized by progressive neurodegeneration, immunodeficiency, increased susceptibility to malignancy and evidence of chronic inflammation. Although different molecular mechanisms underlying AT pathogenesis and its major clinical manifestations have been characterized, the crosstalk among immune dysfunction, inflammatory signaling and neurodegeneration remains difficult to investigate experimentally. Particularly in the context of a rare disease, computational approaches may help integrate diverse biological processes into a coherent systems-level representation. Here, we present UISS-AT, a mechanistic agent-based model of AT developed within the Universal Immune System Simulator (UISS) framework. The model was designed to reproduce core features of AT pathophysiology, including thymic hypoplasia, T-cell deficiency, B-cell defects, impaired V(D)J recombination, class-switch recombination failure, chronic cytokine dysregulation, immunosenescence, susceptibility to infection and progressive Purkinje-cell loss as a neurological endpoint. Simulations were performed on a virtual cohort of 100 AT patients and analyzed at the cohort level over a 10-year time horizon. UISS-AT reproduced the key hallmarks of AT natural history, comprising progressive lymphopenia, humoral immunodeficiency, sustained increases in TNF-α, IL-6 and IL-8 and progressive Purkinje cell degeneration. A treatment layer describing the pharmacodynamic effects of betamethasone and dexamethasone was then implemented, and five clinically informed regimens were evaluated. The model reproduced transient reductions in inflammatory cytokines, partial stabilization of lymphocyte trajectories and temporary slowing of Purkinje-cell loss, consistent with the short-term therapeutic effects reported in AT clinical studies. Together, these results support the biological plausibility of UISS-AT as a mechanistically grounded in silico platform for studying AT disease progression and therapeutic modulation. UISS-AT provides a foundation for future virtual-cohort analyses, comparative evaluation of treatment strategies and model-informed rare-disease research.